Author Topic: (AAN) PML risk cut by extending Tysabri dosing interval  (Read 55 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest
(AAN) PML risk cut by extending Tysabri dosing interval
« on: April 27, 2018, 02:23:48 pm »
From Multiple Sclerosis News Today, April 23, 2018--"#AAN2018: PML Risk Cut by Extending Tysabri Dosing Interval":


https://multiplesclerosisnewstoday.com/2018/04/27/aan2018-pml-risk-cut-by-extending-tysabri-dosing-interval/
« Last Edit: May 18, 2018, 07:46:36 pm by agate »
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest
From Medical News Today, January 7, 2019--"Biogen starts Phase 3B trial to evaluate Tysabri extended interval dosing for RRMS patients." The dosing regimen being studied would involve receiving Tysabri every 6 weeks instead of every 4 weeks.


https://multiplesclerosisnewstoday.com/2019/01/07/phase-3b-trial-tysabri-extended-interval-dosing-rrms/
« Last Edit: January 08, 2019, 03:37:39 pm by agate »
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
82 Views
Last post September 28, 2016, 04:53:58 pm
by agate
0 Replies
49 Views
Last post April 23, 2017, 03:47:31 pm
by agate
0 Replies
173 Views
Last post May 16, 2017, 11:53:39 am
by agate
0 Replies
38 Views
Last post June 11, 2017, 04:49:10 pm
by agate
0 Replies
47 Views
Last post October 11, 2017, 10:47:48 am
by agate